Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
for
Psychosis Associated With Alzheimer's Disease
Location: Bellevue WA, Tigard OR, Las Vegas NV, Redlands CA,
Sponsor: MapLight Therapeutics
Sex: All
Age: 55 - 70+
Code: NCT06887192
Phase 2, Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
for
Schizophrenia
Location: Bellevue WA, Orem UT, Pico Rivera CA, Chino CA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18 - 65
Code: NCT07114874
Phase 3, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: Bellevue WA, Las Vegas NV, West Covina CA, Redlands CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06690398
Phase 3, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Bellevue WA, Glendale CA, Redlands CA, Orange CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase 2, Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Bellevue WA, Walnut Creek CA, Anaheim CA, Cypress TX,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
for
Tardive Dyskinesia
Location: Bellevue WA, Salt Lake City UT, Los Gatos CA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT03062033
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Bellevue WA, Seattle WA, Portland OR, Walnut Creek CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Seattle WA, Calgary, Edmonton, Duarte CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
for
Primary Myelofibrosis,
Location: Seattle WA, Vancouver, Houston TX, Ann Arbor MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06517875
Phase 2, Recruiting
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
for
Relapsed or Refractory Hematologic Malignancies
Location: Seattle WA, Fairway KS, Lafayette IN, Washington DC,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03838926
Phase 1, Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Seattle WA, Kirkland WA, Spokane WA, Salt Lake City UT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Reach Out and Read (ROR) in the Neonatal Intensive Care Unit (NICU) Study
for
Anxiety, Parent-Child Relations, Literacy
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 0
Code: NCT06002360
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Seattle WA, Portland OR, Vancouver, San Francisco CA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Seattle WA, Portland OR, Bakersfield CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase 2, Recruiting
Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
for
Juvenile Idiopathic Arthritis
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 6 - 11
Code: NCT01434082
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
for
Bladder Cancer, Recurrent Bladder Cancer,
Location: Seattle WA, Iowa City IA, Nashville TN, Columbus OH,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07225127
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Seattle WA, Portland OR, San Francisco CA, Glendale CA,